Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...
STAT7h
Medicare removes sexual orientation, gender identity questions from enrollment forms
The U.S. agency that oversees Medicare is taking out questions on enrollment application forms that ask people about their ...